- Raised $39M Series B led by OurCrowd, Jul 2021
- Raised $7.3M Series A led by IT-Farm, Apr 2018
- Raised $2.6M grant, May 2018
About
BRAIN.Q is an Israeli health-tech company focused on revolutionizing stroke recovery and neurological disorders through innovative, non-invasive therapies. The company utilizes advanced AI-powered technology to develop network-targeting electromagnetic precision therapy, designed to enhance and accelerate brain recovery following ischemic stroke. Their system combines a wearable helmet delivering low-intensity, frequency-tuned electromagnetic stimulation with a personalized rehabilitation program managed through a cloud-based AI platform, enabling both hospital and home-based treatment. BRAIN.Q has received FDA Breakthrough Device Designation, CE Mark certification in the European Union, and AMAR approval from Israel's Health Ministry. The company is actively progressing its pivotal EMAGINE II study in the U.S., aiming to secure FDA clearance for its Q Therapeutic System.
Funding history · 4 rounds · $52.4M total
Headcount over time
Q&A
- What is BRAIN.Q's primary focus?
- BRAIN.Q is an Israeli health-tech company that develops AI-powered electromagnetic therapy for stroke recovery and other neurological disorders.
- What is the current employee count for BRAIN.Q?
- BRAIN.Q currently has 38 employees, falling within the 11-50 employee bucket.
- What is BRAIN.Q's total funding to date?
- BRAIN.Q has raised a total of $52.4 million USD.
- When did BRAIN.Q receive its Series B funding round?
- BRAIN.Q received its Series B funding round in August 2021, with lead investors including Hanaco Ventures and Dexcel Pharma
- What regulatory designations has BRAIN.Q received for its technology?
- BRAIN.Q has received FDA Breakthrough Device Designation, CE Mark certification in the European Union, and AMAR approval from Israel's Health Ministry.
- What is the status of BRAIN.Q's clinical trials?
- BRAIN.Q is actively progressing its pivotal EMAGINE II study in the U.S., aiming to secure FDA clearance for its Q Therapeutic System.
- What type of technology does BRAIN.Q utilize?
- BRAIN.Q utilizes advanced AI-powered technology to develop network-targeting electromagnetic precision therapy.
- Where is BRAIN.Q headquartered?
- BRAIN.Q is headquartered in Jerusalem, Israel.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | brainqtech.com |
|---|---|
| linkedin.com/company/5549321 | |
| facebook.com/BrainQTech | |
| YouTube | youtube.com/@BrainQTech |
Identifiers & details
| Legal name | BrainQ Technologies Ltd. |
|---|---|
| Founded | 2016-8 |
| Employees (exact) | 38 |
| Offices | Englewood Cliffs |
Radar intelligence
Patents
| EPO | 7 |
|---|
Web history (Wayback)
| Domain | brainqtech.com |
|---|
Certificate / subdomain footprint
| Subdomains | 102 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514654904 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-08-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — other (1), shares_capital (1) |
| Registered address | האוניברסיטה העברית 3.7 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-23 | שינוי בתקנון |
| 2026-04-12 | העברת מניות |